| 1 |
cyclosporin A
(7564 times)
|
Pharmacology
(912 times)
|
P-gp (237 times)
MMF (211 times)
GVHD (210 times)
|
1979 Cyclosporin A: in vivo and in vitro suppression of rat T-lymphocyte function.
|
| 2 |
cyclosporine Neoral
(5 times)
|
Transplantation
(5 times)
|
AUC (3 times)
TAC (2 times)
CI (1 time)
|
2004 Baseline immunosuppression is associated with histological findings in early protocol biopsies.
|
| 3 |
chronic administration of cyclosporine
(3 times)
|
Neoplasms
(1 time)
|
AUC (1 time)
BUN (1 time)
CAT (1 time)
|
2001 Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.
|
| 4 |
Cross-sectional analysis
(3 times)
|
Ophthalmology
(1 time)
|
BMD (1 time)
BT (1 time)
CME (1 time)
|
2011 Simple estimation of clinically relevant lesion volumes using spectral domain-optical coherence tomography in neovascular age-related macular degeneration.
|
| 5 |
drugs-cyclosporin A
(3 times)
|
Biomedical Engineering
(1 time)
|
EC (1 time)
GC (1 time)
LPS (1 time)
|
2000 Immunophilins: switched on protein binding domains?
|
| 6 |
acute-cyclosporin A
(2 times)
|
Nephrology
(1 time)
|
ADM (1 time)
DNR (1 time)
FF (1 time)
|
1989 Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects.
|
| 7 |
cases and to cyclosporine
(2 times)
|
Transplantation
(1 time)
|
aGVHD (1 time)
ATG (1 time)
cGVHD (1 time)
|
2006 Tacrolimus-related neurologic and renal complications in liver transplantation: A single-center experience.
|
| 8 |
chitosan aerogel
(2 times)
|
Carbohydrates
(1 time)
|
CSHA (1 time)
|
2016 An environment-friendly and multi-functional absorbent from chitosan for organic pollutants and heavy metal ion.
|
| 9 |
Chondroitin sulfate
(2 times)
|
Biomedical Engineering
(1 time)
|
PLGA (2 times)
CD (1 time)
INS (1 time)
|
2007 Protein complexed with chondroitin sulfate in poly(lactide-co-glycolide) microspheres.
|
| 10 |
CNIs, such as cyclosporin A
(2 times)
|
Transplantation
(1 time)
|
AZA (1 time)
CI (1 time)
ESKD (1 time)
|
2009 Influence of CYP3A5 and ABCB1 gene polymorphisms on calcineurin inhibitor-related neurotoxicity after hematopoietic stem cell transplantation.
|
| 11 |
co-administered with cyclosporin
(2 times)
|
Pharmacy
(1 time)
|
MPA (2 times)
TAC (2 times)
AUC (1 time)
|
2006 Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
|
| 12 |
corticosteroids and cyclosporine
(2 times)
|
Allergy and Immunology
(1 time)
|
BD (1 time)
DEX (1 time)
EAU (1 time)
|
1987 Cyclosporine and dexamethasone inhibit T-lymphocyte MHC class II antigens and IL-2 receptor expression in experimental autoimmune uveitis.
|
| 13 |
corticosteroids, anakinra, and cyclosporine
(2 times)
|
Medicine
(1 time)
|
CSF (1 time)
CTLs (1 time)
HLH (1 time)
|
2018 Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature.
|
| 14 |
corticosteroids, azathioprine, cyclosporine
(2 times)
|
Transplantation
(1 time)
|
---
|
2004 Optimization of the use of cyclosporine in renal transplantation.
|
| 15 |
cyclosporin A ophthalmic emulsion
(2 times)
|
Ophthalmology
(2 times)
|
IL-6 (1 time)
RT-PCR (1 time)
|
2000 Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion.
|
| 16 |
anti-cyclosporine
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1991 Characterization of a monoclonal anti-idiotypic antibody that mimics cyclosporine A in a single binding system.
|
| 17 |
anti-T-cell antibody, cyclophosphamide, cyclosporine
(1 time)
|
Transplantation
(1 time)
|
BM (1 time)
BW (1 time)
HSCT (1 time)
|
2007 In pursuit of the ultimate: the initial Ahmedabad journey toward transplantation tolerance.
|
| 18 |
blocker-cyclosporin A
(1 time)
|
Biochemistry
(1 time)
|
AP-1 (1 time)
Con A (1 time)
IFNgamma (1 time)
|
2004 Volvariella volvacea lectin activates mouse T lymphocytes by a calcium dependent pathway.
|
| 19 |
cadaveric kidney transplantation using cyclosporine
(1 time)
|
Health Services Research
(1 time)
|
AZA (1 time)
ESRD (1 time)
|
1986 A cost-effectiveness analysis of cyclosporine in cadaveric kidney transplantation.
|
| 20 |
calcineurin activity nor its inhibition by cyclosporine
(1 time)
|
Transplantation
(1 time)
|
---
|
1997 Calcineurin activity in children with renal transplants receiving cyclosporine.
|
| 21 |
calcineurin inhibitors, tacrolimus or modified cyclosporine
(1 time)
|
Transplantation
(1 time)
|
USRDS (1 time)
|
2005 Renal graft survival and calcineurin inhibitor.
|
| 22 |
calcineurin phosphatase inhibitors, cyclosporine
(1 time)
|
Biochemistry
(1 time)
|
---
|
2003 Cloning and characterization of N4WBP5A, an inducible, cyclosporine-sensitive, Nedd4-binding protein in human T lymphocytes.
|
| 23 |
calcium antagonist may have a renoprotective against cyclosporin
(1 time)
|
Nephrology
(1 time)
|
BP (1 time)
FF (1 time)
GFR (1 time)
|
1998 The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
|
| 24 |
Calcium antagonists may reduce the nephrotoxicity of cyclosporine
(1 time)
|
Nephrology
(1 time)
|
ATG (1 time)
ATGAM (1 time)
|
1997 A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients.
|
| 25 |
Campath-1H and received sirolimus or cyclosporine
(1 time)
|
Nephrology
(1 time)
|
Treg (1 time)
|
2007 Regulatory T cells and T cell depletion: role of immunosuppressive drugs.
|
| 26 |
can antagonize the cyclosporine
(1 time)
|
Transplantation
(1 time)
|
---
|
1997 Investigation of a possible interaction between ciprofloxacin and cyclosporine in renal transplant patients.
|
| 27 |
can reduce the dosage of cyclosporine
(1 time)
|
Pharmacology
(1 time)
|
---
|
2015 Diltiazem augments the influence of MDR1 genotype status on cyclosporine concentration in Chinese patients with renal transplantation.
|
| 28 |
capsid stability were assessed using a cyclosporine
(1 time)
|
Virology
(1 time)
|
CTL (1 time)
|
2016 Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
|
| 29 |
carbamazepine and cyclosporine
(1 time)
|
Drug Therapy
(1 time)
|
---
|
1995 Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients.
|
| 30 |
carboxylic acid, was in clinical development in combination with cyclosporine
(1 time)
|
Pharmacology
(1 time)
|
BQR (1 time)
|
1998 Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipients.
|
| 31 |
cardiac allograft survival and is synergistic with cyclosporine
(1 time)
|
General Surgery
(1 time)
|
BN (1 time)
LEW (1 time)
LPS (1 time)
|
1993 Lipopolysaccharide pretreatment of cyclosporine-treated rats enhances cardiac allograft survival.
|
| 32 |
cardiac allografts and has demonstrated synergy with cyclosporine
(1 time)
|
General Surgery
(1 time)
|
RPM (1 time)
|
1994 Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
|
| 33 |
cardiac allografts in rats treated with cyclosporine
(1 time)
|
Transplantation
(1 time)
|
Th (1 time)
|
1985 Phenotype, activation status, and suppressor activity of host lymphocytes during acute rejection and after cyclosporine-induced unresponsiveness of rat cardiac allografts.
|
| 34 |
cardiovascular risk factors in two phase II studies comparing cyclosporine
(1 time)
|
Transplantation
(1 time)
|
---
|
2003 Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation.
|
| 35 |
cardiovascular toxicity by cyclosporine
(1 time)
|
Nephrology
(1 time)
|
CAT-1 (1 time)
eNOS (1 time)
HUVEC (1 time)
|
2013 Cyclosporine attenuates arginine transport, in human endothelial cells, through modulation of cationic amino acid transporter-1.
|
| 36 |
carried out, particularly focussing our attention on cyclosporine
(1 time)
|
Transplantation
(1 time)
|
DKG (1 time)
MMF (1 time)
MPA (1 time)
|
2001 The kidney transplant program at the Bergamo Center.
|
| 37 |
carvedilol and cyclosporine
(1 time)
|
Transplantation
(1 time)
|
CVR (1 time)
|
1997 Elevation of cyclosporin A blood levels during carvedilol treatment in renal transplant patients.
|
| 38 |
case series of dogs with presumed ICH treated with cyclosporine
(1 time)
|
Internal Medicine
(1 time)
|
ICH (1 time)
|
2019 Retrospective evaluation of cyclosporine in the treatment of presumed idiopathic chronic hepatitis in dogs.
|
| 39 |
cases singular or complicated cyclosporine
(1 time)
|
Transplantation
(1 time)
|
---
|
1998 Is kidney graft biopsy indicated in recipients with newly developed, microscopic hematuria?
|
| 40 |
catalyzing the site-specific hydroxylation of the immunosuppressant cyclosporine
(1 time)
|
Microbiology
(1 time)
|
CsA-4-OH (1 time)
CTAB (1 time)
|
2015 Reconstitution of the In Vitro Activity of the Cyclosporine-Specific P450 Hydroxylase from Sebekia benihana and Development of a Heterologous Whole-Cell Biotransformation System.
|
| 41 |
cell activity by cyclosporine
(1 time)
|
Transplantation
(1 time)
|
---
|
1986 Modulation of host defenses against pyogenic microorganisms by cyclosporine.
|
| 42 |
cell-mediated and relatively resistant to cyclosporine
(1 time)
|
Transplantation
(1 time)
|
IFN-gamma (1 time)
IL (1 time)
NOD (1 time)
|
1998 Combination therapy with cyclosporine and interleukin-4 or interleukin-10 prolongs survival of synergeneic pancreatic islet grafts in nonobese diabetic mice: islet graft survival does not correlate with mRNA levels of type 1 or type 2 cytokines, or transforming growth factor-beta in the islet grafts.
|
| 43 |
cells and maintenance suppression with low-dose cyclosporine
(1 time)
|
Transplantation
(1 time)
|
AZ (1 time)
CP (1 time)
|
1988 Low-dose cyclosporine maintenance therapy after immunosuppressive induction in a rat cardiac transplant model.
|
| 44 |
cells are inhibited by cyclosporine
(1 time)
|
Antineoplastic Agents
(1 time)
|
DFMO (1 time)
|
1988 Differential sensitivity of pancreatic and colon cancer to cyclosporine and alpha-difluoromethylornithine in vivo.
|
| 45 |
cells suggest that cyclosporin
(1 time)
|
Dentistry
(1 time)
|
---
|
1997 [Cytokines and cytokine receptors in mouth mucosa of immune suppressed patients].
|
| 46 |
cells, addition of cyclosporine
(1 time)
|
Microbiology
(1 time)
|
EBV (1 time)
IRF4 (1 time)
KSHV (1 time)
|
2014 Murine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cells.
|
| 47 |
cephalosporine A
(1 time)
|
Anti-Bacterial Agents
(1 time)
|
---
|
2021 Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.
|
| 48 |
cessation of long-term cyclosporin
(1 time)
|
General Surgery
(1 time)
|
---
|
1993 Extended survival and function of peripheral nerve allografts after cessation of long-term cyclosporin administration in rats.
|
| 49 |
changed; specifically, the cyclosporine
(1 time)
|
Transplantation
(1 time)
|
AZA (1 time)
BP (1 time)
BW (1 time)
|
2005 Effect of mycophenolate mofetil on kidney graft function and body weight in patients with chronic allograft nephropathy.
|
| 50 |
changes; an alternate hypothesis, however, may be that cyclosporine
(1 time)
|
Toxicology
(1 time)
|
---
|
1993 An in vitro model of cyclosporine-induced nephrotoxicity.
|
| 51 |
channel antagonists on the metabolism of cyclosporine
(1 time)
|
Pharmacology
(1 time)
|
---
|
1989 Calcium channel antagonists and cyclosporine metabolism: in vitro studies with human liver microsomes.
|
| 52 |
characterize a possible plasma membrane receptor for cyclosporine
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1983 Binding of cyclosporine by human lymphocytes and phospholipid vesicles.
|
| 53 |
characterized a series of cyclosporine
(1 time)
|
Gastroenterology
(1 time)
|
CN (1 time)
Cyps (1 time)
HBV (1 time)
|
2016 Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.
|
| 54 |
chemosensitizer, such as cyclosporin A
(1 time)
|
Neoplasms
(1 time)
|
ADR (1 time)
CsH (1 time)
IC50 (1 time)
|
1994 Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
|
| 55 |
Cholestatic effects have been reported for cyclosporine
(1 time)
|
Transplantation
(1 time)
|
BADF (1 time)
BAIF (1 time)
BASR (1 time)
|
1999 Influence of tacrolimus on bile acid and lipid composition in continuously drained bile using a rat model. Comparative study with cyclosporine.
|
| 56 |
chromatography estimations of trough plasma cyclosporin
(1 time)
|
Nephrology
(1 time)
|
---
|
1988 Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
|
| 57 |
Chromosome-type aberrations
(1 time)
|
Toxicology
(1 time)
|
Cd (1 time)
MN (1 time)
|
1994 Comparison of chromosome aberrations and micronuclei in testing genotoxicity in humans.
|
| 58 |
chronic allograft dysfunction even in the absence of cyclosporine
(1 time)
|
Transplantation
(1 time)
|
ET-1 (1 time)
|
2002 Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
|
| 59 |
chronic allograft liver rejection model induced by low-dose immunosuppressive cyclosporine
(1 time)
|
Biology
(1 time)
|
BN (1 time)
DA (1 time)
|
2011 Humoral immunity-mediated chronic rejection in liver transplantation is associated with predominant IL-10 expression.
|
| 60 |
chronic allograft nephropathy, and cyclosporine
(1 time)
|
Nephrology
(1 time)
|
GPT (1 time)
|
2005 Long-term beneficial effect of tacrolimus conversion on renal transplant recipients.
|
| 61 |
chronic liver disease and the use of cyclosporin
(1 time)
|
Transplantation
(1 time)
|
---
|
2002 Nocardiosis in tropical renal transplant recipients.
|
| 62 |
chronically administered low doses of cyclosporine
(1 time)
|
Pharmacology
(1 time)
|
---
|
1994 The effect of neonatal immunoregulatory cells and cyclosporine on the heart allograft survival in rats.
|
| 63 |
ciclosporin A group
(1 time)
|
Complementary Therapies
(1 time)
|
BrdU (1 time)
DC (1 time)
MSCA (1 time)
|
2009 Mesenchymal stem cells transplantation mildly ameliorates experimental diabetic nephropathy in rats.
|
| 64 |
ciclosporin A modified
(1 time)
|
Health Services
(1 time)
|
---
|
2009 Healthcare costs in renal transplant recipients using branded versus generic ciclosporin.
|
| 65 |
cimetidine and cyclosporine
(1 time)
|
Gastroenterology
(1 time)
|
---
|
1992 The effect of cimetidine on cyclosporine A levels in liver transplant recipients: a preliminary report.
|
| 66 |
circumstances force some stable renal transplant recipients to discontinue cyclosporine
(1 time)
|
Nephrology
(1 time)
|
NORD (1 time)
|
1996 Benefits of continued cyclosporine through an indigent drug program.
|
| 67 |
citric acid-functionalized chitosan
(1 time)
|
Polymers
(1 time)
|
CA (1 time)
CS (1 time)
|
2022 Electrospun Nanofibrous Membranes Based on Citric Acid-Functionalized Chitosan Containing rGO-TEPA with Potential Application in Wound Dressings.
|
| 68 |
clear, aqueous solution of cyclosporine
(1 time)
|
Ophthalmology
(1 time)
|
AEs (1 time)
LLOQ (1 time)
|
2019 A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers.
|
| 69 |
clearly attributable to cyclosporine
(1 time)
|
Nephrology
(1 time)
|
---
|
2004 Hyperuricemia in kidney transplantation.
|
| 70 |
clinical applications in the United States: cyclosporine
(1 time)
|
Chemistry, Clinical
(1 time)
|
LC (1 time)
MEIA (1 time)
MPA (1 time)
|
2001 Therapeutic drug monitoring for immunosuppressants.
|
| 71 |
clinical aspects after kidney transplantation using cyclosporine
(1 time)
|
General Surgery
(1 time)
|
AZ (1 time)
|
1986 Improved outcome of renal transplantation with cyclosporine compared with azathioprine--experience in 33 recipients followed for over one year.
|
| 72 |
clinical settings as cyclosporine
(1 time)
|
Transplantation
(1 time)
|
IGF-I (1 time)
|
2003 Insulin-like growth factor-I enhances choleretic action of FK506 in rats.
|
| 73 |
clinical significance of cyclosporine
(1 time)
|
Biochemistry
(1 time)
|
AP (1 time)
AUC (1 time)
|
2006 Is absorption profile of cyclosporine really important for effective immunosuppression?
|
| 74 |
closely correlated with the level of P-450
(1 time)
|
Pharmacology
(1 time)
|
NF (1 time)
|
1989 Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily.
|
| 75 |
CMV and intravenous cyclosporine
(1 time)
|
Gastroenterology
(1 time)
|
---
|
2011 A case of ulcerative colitis accompanied with myelodysplastic syndrome successfully treated by cyclosporine.
|
| 76 |
CN, as demonstrated by CN inhibition with cyclosporine
(1 time)
|
Cell Biology
(1 time)
|
NFAT (1 time)
PE (1 time)
PKC (1 time)
|
2009 Effects of thapsigargin and phenylephrine on calcineurin and protein kinase C signaling functions in cardiac myocytes.
|
| 77 |
Coadministration of diltiazem with cyclosporine
(1 time)
|
Cardiology
(1 time)
|
---
|
1992 Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation.
|
| 78 |
Coadministration of the calcineurin inhibitor cyclosporine
(1 time)
|
Toxicology
(1 time)
|
ROS (1 time)
SRL (1 time)
|
2010 Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism.
|
| 79 |
coefficients of variation ranged between 3.0-4.1
(1 time)
|
Chemistry, Clinical
(1 time)
|
ACMIA (1 time)
CLIA (1 time)
ECLIA (1 time)
|
2017 Analytical performance evaluation of the Elecsys Cyclosporine and Elecsys Tacrolimus assays on the cobas e411 analyzer.
|
| 80 |
collections among patients treated with sirolimus-cyclosporine
(1 time)
|
Transplantation
(1 time)
|
---
|
2002 Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients.
|
| 81 |
combined with a triple immunosuppressive protocol including prednisolone,cyclosporine microemulsion
(1 time)
|
Kidney Diseases
(1 time)
|
MMF (1 time)
|
2013 Efficacy of anti-interleukin-2 receptor antibody (daclizumab) in reducing the incidence of acute rejection after renal transplantation.
|
| 82 |
common adverse effect of cyclosporine
(1 time)
|
Cardiology
(1 time)
|
---
|
2007 Possible everolimus-induced, severe, reversible encephalopathy after cardiac transplantation.
|
| 83 |
common after heart transplantation, and is related to ciclosporin
(1 time)
|
Nephrology
(1 time)
|
AZA (1 time)
SRL (1 time)
|
2009 Transfer from ciclosporin to mycophenolate-sirolimus immunosuppression for chronic renal disease after heart transplantation: safety and efficacy of two regimens.
|
| 84 |
common and clinically important side effect of cyclosporine
(1 time)
|
Pharmacology
(1 time)
|
BUN (1 time)
ROS (1 time)
TBARS (1 time)
|
2001 Quercetin, a bioflavonoid, protects against oxidative stress-related renal dysfunction by cyclosporine in rats.
|
| 85 |
common and important side-effect of cyclosporin
(1 time)
|
Nephrology
(1 time)
|
ANF (1 time)
GFR (1 time)
RBF (1 time)
|
1994 Prevention of acute cyclosporin nephrotoxicity by verapamil and atrial natriuretic factor in the rat.
|
| 86 |
comparators administered with a cyclosporine
(1 time)
|
Transplantation
(1 time)
|
AZA (1 time)
PRED (1 time)
|
2003 Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal transplantation.
|
| 87 |
compare outcomes in patients receiving either cyclosporine
(1 time)
|
Transplantation
(1 time)
|
CI (1 time)
CMV (1 time)
DFI (1 time)
|
1995 Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression.
|
| 88 |
Compared side by side, cyclosporine
(1 time)
|
Nerve Degeneration
(1 time)
|
ALS (1 time)
CM (1 time)
MNs (1 time)
|
2022 Autologous treatment for ALS with implication for broad neuroprotection.
|
| 89 |
compared the pharmacokinetic parameters obtained from cyclosporine
(1 time)
|
Transplantation
(1 time)
|
AUC (1 time)
TLs (1 time)
|
1995 Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.
|
| 90 |
comparing sirolimus versus cyclosporine
(1 time)
|
Transplantation
(1 time)
|
MMF (1 time)
|
2005 Bone metabolism in renal transplant patients treated with cyclosporine or sirolimus.
|
| 91 |
comparing SRL and cyclosporin A
(1 time)
|
Transplantation
(1 time)
|
MCV (1 time)
MMF (1 time)
SRL (1 time)
|
2005 Marked erythrocyte microcytosis under primary immunosuppression with sirolimus.
|
| 92 |
comparison of single and repeated peroral administration of cyclosporine
(1 time)
|
Medicine
(1 time)
|
AChE (1 time)
MEOTA (1 time)
|
2003 Antiacetylcholinesterase activity of cyclosporine--a comparison of single and repeated administration and effect of 7-methoxytacrine.
|
| 93 |
complication associated with cyclosporine
(1 time)
|
Transplantation
(1 time)
|
EMT (1 time)
|
2015 MicroRNA-494 promotes cyclosporine-induced nephrotoxicity and epithelial to mesenchymal transition by inhibiting PTEN.
|
| 94 |
complications, and duration of effect of a cyclosporine
(1 time)
|
Ophthalmology
(1 time)
|
ERU (1 time)
|
2010 Long-term outcome after implantation of a suprachoroidal cyclosporine drug delivery device in horses with recurrent uveitis.
|
| 95 |
compounds such as Cyclosporine A
(1 time)
|
Pharmacology
(1 time)
|
Con A (1 time)
Cyp A (1 time)
IL-2 (1 time)
|
2016 Identification of Spongionella compounds as cyclosporine A mimics.
|
| 96 |
compounds-cyclosporin A
(1 time)
|
|
MPA (1 time)
mPRED (1 time)
|
2019 Immunosuppressive Compounds Affect the Fungal Growth and Viability of Defined Aspergillus Species.
|
| 97 |
concentration ranges of 0.1-10.0 ng/mL
(1 time)
|
Drug Therapy
(1 time)
|
MPA (1 time)
TDM (1 time)
|
2017 Simultaneous Determination of Protein-Unbound Cyclosporine A and Mycophenolic Acid in Kidney Transplant Patients Using Liquid Chromatography-Tandem Mass Spectrometry.
|
| 98 |
concentrations (IC(50)'s) ranged from 511-771 ng/ml
(1 time)
|
Allergy and Immunology
(1 time)
|
TRL (1 time)
|
2004 In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.
|
| 99 |
concentrations 100-fold lower than cyclosporine
(1 time)
|
Allergy and Immunology
(1 time)
|
---
|
1990 Effect of FK-506 and cyclosporine on human T and B lymphoproliferative responses.
|
| 100 |
CONCEPT study, a prospective randomized study comparing a cyclosporine
(1 time)
|
Nephrology
(1 time)
|
MMF (1 time)
SRL (1 time)
VEGF (1 time)
|
2011 Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial growth factor.
|
A Search Service for Abbreviation / Long Form